Management of drooling of saliva

British Journal of Medical Practitioners

Volumn 5, Issue 1, 2012, Pages

  Bavikatte, Ganesh ^a   Sit, Poh Lin ^b   Hassoon, Ali ^b  

^a Speciality Registrar Rehabilitation Medicine   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZATROPINE; BOTULINUM TOXIN A; CAPSAICIN; CARICA PAPAYA EXTRACT; CHOLINESTERASE INHIBITOR; CISAPRIDE; GLYCOPYRRONIUM BROMIDE; GRAPE SEED EXTRACT; LITHIUM; MERCURY; MODAFINIL; PESTICIDE; RANITIDINE; SCOPOLAMINE; SNAKE VENOM; TRANQUILIZER; TRIHEXYPHENIDYL;

ARTICLE; ASPIRATION; BACTERIAL INFECTION; BEHAVIOR CHANGE; BEHAVIOR THERAPY; BONE NECROSIS; CEREBRAL PALSY; DEHYDRATION; DENTAL CARIES; DRUG WITHDRAWAL; DYSPHAGIA; EATING HABIT; ESTHETICS; FACIAL NERVE INJURY; FLUID INTAKE; FLUSHING; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERSALIVATION; IRRITABILITY; LASER COAGULATION; MASTICATION; MEDICAL ASSESSMENT; MOTOR NEURON DISEASE; MOUTH INFECTION; MOUTH INFLAMMATION; MUCOSA INFLAMMATION; NEUROMUSCULAR FACILITATION; NURSING CARE; ORAL SURGERY; PARKINSON DISEASE; PAROTID GLAND DISEASE; PATHOPHYSIOLOGY; PATIENT POSITIONING; PERSONAL HYGIENE; PREGNANCY; PSEUDOBULBAR PALSY; RABIES; RADIOTHERAPY; SELF ESTEEM; SIDE EFFECT; SKIN MACERATION; SOCIAL STIGMA; SPEECH THERAPY; STROKE; SWEATING; TONSILLITIS; TOOTH PROSTHESIS; UNSPECIFIED SIDE EFFECT; URINE RETENTION; XEROSTOMIA;

EID: 84860634136     PISSN: 17578515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Stuchell RN, Mandel ID. Salivary gland dysfunction and swallowing disorders. Otolayngol Clin North Am 1988;21:649-61.
2. Costanzo, L. Text book of Physiology, 3rd edition. Saunders Elsevier. ISBN 10:1-4160-2320-8.
3. Sochaniwskyj AE. Drool Quantification: noninvasive technique. Arch Phys Med Rehabil 1982;63:605-7.
4. Neil G. Hockstein, Daniel S. Samadi, Kristin Gendron, Steven D. Handler, Am Fam Physician 2004;69:2628-34.
5. Louise Cummings, Text book of Clinical Linguistics, edin univ press, page 95-99, 2008.
6. Hilary Johnson, Amanda Scott, Text book on A practical approach to saliva control page31, 86
7. Giles R, Naummann M, Werner E, Riemann M, Beck I, Puls I, Reinners C, Toyka KV. Injection of botulinum toxin A in to salivary glands improve sialorrhoea in amyotropic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-3.
8. Jongerius PH, Rotteveel JJ, Van Limbeck J, Gabreels FJM, Van Ilulst KBS, Van Den Ilogen FJA. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004;63:1371-5.
9. Boothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood Camfied CS, Camfield PR. Botulinum toxin A as a treatment for excessive drooling in children. Paediatr Neurology 2002; 27(1):18-22.
10. Johnson H, Scott A. 1993; Book on practical approach to saliva control and communication; 1993
11. Scully C, Limeres J, Gleeson M, Tomás I, Diz P. Drooling, J Oral Pathol Med. 2009 Apr;38(4):321-7. Epub 2009 Feb 23
12. Suskind DL, Tilton A. Clinical study of botulinum toxin-A in the treatment of sialorrhoea in children with cerebral palsy. Laryngoscope 2002. 112:73-81.
13. Crysdale WS, McCann C, Roske L. Saliva control issues in the neurologically challenged: a 30 year experience in team management. Int J Paedatr Otolarynol: 2006; 70: 519-527.
14. Sullivan PB, Lambert B, Rose M. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding study. Dev Med Child Neuol 2000;42:674-680.
15. Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC. Drooling of saliva: A Review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):48-57.
16. Hockstein NG, Samadi DS, Gendron K, Handler SD, Sialorrhoea: a management Challenge, Am Fam Physician 2004; 69:2628-2634.
17. Jongerius PH, Van Tiel P, Van Limbeek J, A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 2003; 88: 911-914.
18. Scott, A., & Staios, G. (1993). Oral-facial facilitation. In J. Hilary & A. Scott (Eds.), A practical approach to saliva control (pp. 32-42). San Antonio, TX: Communication Skill Builders
19. Potulska A, Friedman A. Controlling sialorrhoea: a review of available treatment options. Expert Opin Pharmacother. 2005 Aug;6(9):1551-4.
20. Mato Montero A, Limeres Posse J, Tomás Carmona I, Fernández Feijoo J, Diz Dios P. Med Oral Patol Oral Cir Bucal. 2008 Jan 1;13(1):E27-30.
21. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000 Dec;154(12):1214-8.
22. Blasco P.A. Glycopyrrolate treatment of chronic drooling. Archives of paediatric adolescent medicine, vol 150, sept 1996:932-935.
23. Heine R.G. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Developmental medicine and child neurology, 1996, vol 38, 1030-36.
24. Blasco P.A. (2002) Management of drooling: 10 years after the consortium on drooling, 1990. Dev. Med. Child Neurol. 44, 778-781
25. Camp-Bruno J.A., Winsberg B.G., Green-Parsons A.R. (1989) Efficacy of benztropine therapy for drooling. Dev. Med. Child Neurol. 31, 309-319
26. Lloyd Faulconbridge R.V., Tranter R.M., Moffat V. Review of management of drooling problems in neurologically impaired children: A review of methods and results over 6 years at Chailey Heritage clinical services. Clin. Otolaryngol. Allied Sci. (2001) 26, 76-81
27. Porta M., Gamba M., Bertacchi G. et al. (2001) Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J. Neurol. Neurosurg. Psychiatry 70, 538-540
28. Jongerius P.H., van den Hoogen F.J., van Limbeek J. et al. (2004) Effect of botulinum toxin in the treatment of drooling: A controlled clinical trial. Pediatrics 114, 620-627
29. Diamant H, Kumlien A. A treatment for drooling in children with cerebral palsy. J Laryngol Otol. 1974;88(1):61-64.
30. Peter Misra. Botulinum toxin as a treatment for drooling of saliva. ACNR; nov/dec 2002: v2 n2 11-12.
31. Dayse Manrique, application of botulinum toxin to reduce the saliva in patients with amyotropic lateral sclerosis; Rev Bras Otorrinolaringol; sept-oct 2005, v.71, n.5, 566-69.
32. Borg M, Hirst, the role of radiation therapy in the management of sialorrhea international journal of radiation oncology, Biology and physics; 1998 jul: 1113-9.
33. Crysdale W.S. Management of drooling in individuals with neurodisability: a surgical experience. Developmental medicine and child neurology. 2001(43) 379-383.
34. O'Dwyer T.P. The surgical management of drooling-a 15 year follow up. Clinical Otolaryngology. 1997(22) 284-287.
35. Chang C. Intraductal laser photocoagulation of the bilateral parotid ducts for reduction of drooling in patients with cerebral palsy. Plastic and reconstructive Surgery. 2001(107) 907-913.
36. Jeremy Reed, Carolyn K. Mans, Scott E. Brietzke, MPH Surgical Management of Drooling A Meta-analysis. Arch Otolaryngol Head Neck Surg. 2009;135(9):924-931.